Select Publications

Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas B, Hansen RA, Morgan LC, Williams SC, Lohr KN. Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults. Comparative Effectiveness Review No. 11. (Prepared by RTI-University of North Carolina Evidence-based Practice Center under Contract No. 290-02-0016.) Rockville, MD: Agency for Healthcare Research and Quality. November 2007. Available at: www.effectivehealthcare.ahrq.gov/reports/final.cfm

Gartlehner G, Hansen RA, Thieda P, DeVeaugh-Geiss AM, Gaynes BN, Krebs EE, Morgan LC, Lux LJ, Shumate JA, Lohr KN.  Comparative Effectiveness of Pharmacologic Treatment of Depression (Prepared by RTI-UNC under Contract No. 290-02-0016, TO #7.) Rockville, MD: Agency for Healthcare Research and Quality. April, 2006. Available at: www.effectivehealthcare.ahrq.gov/reports/final.cfm

Gartlehner G,  Hansen RA, Nissman D, Lohr KN, Carey TS. Criteria for Distinguishing Effectiveness from Efficacy Trials in Systematic Reviews. Technical Review 12. AHRQ Publication No. 06-0046. Rockville, MD: Agency for Healthcare Research and Quality. 2006; available at http://www.ahrq.gov/downloads/pub/evidence/pdf/efftrials/efftrials.pdf

Gartlehner G, Hansen RA, Thieda P, Jonas B, Lohr KN, Carey TS.  Drug class review on targeted immune modulators.  Final AHRQ-approved report available at http://www.ohsu.edu/drugeffectiveness/reports/draft.cfm; accessed November 14, 2005.

Hansen RA, Gartlehner G, Kaufer DJ, Lohr KN, Randolph LC, and Carey T.  Drug class review on Alzheimer’s drugs.  Final AHRQ-approved report available at http://www.ohsu.edu/drugeffectiveness/reports/draft.cfm; most recent update, February, 2006.

Hansen RA, Gartlehner G, Lohr KN, Carson S, and Carey T.  Drug class review on inhaled corticosteroids.  Final AHRQ-approved report available at http://www.ohsu.edu/drugeffectiveness/reports/draft.cfm; most recent update, December, 2005.

Gartlehner G, Hansen RA, Kahwati L, Lohr KN, Gaynes B, and Carey T.  Drug class review on second-generation antidepressants.  Final AHRQ-approved report available at http://www.ohsu.edu/drugeffectiveness/reports/draft.cfm; most recent update, May, 2006.

Hansen RA, Clarke Henley A, Brouwer ES, Oraefo AN, Roth MT. Geographic information system mapping as a tool to assess nonresponse bias in survey research. Research in Social and Administrative Pharmacy: In Press.

Lu YJ, Farley JF, Hansen RA. Promotion and market share in the proton pump inhibitor market: a case study. Journal of Pharmaceutical Marketing and Management: In Press

Hansen RA, Gartlehner G, Powell G, Sandler RS. Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clinical Gastroenterology and Hepatology: In press.

Hansen RA, Gartlehner G, Lohr KN, Kaufer DI. Functional outcomes of drug treatment in Alzheimer’s disease: A systematic review and meta-analysis. Drugs and Aging: In press.

Gartlehner G, Hansen RA, Jonas B, Thieda T, Lohr KN. The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: A systematic review and meta-analysis. The Journal of Rheumatology. 2006;33(12):1-11.

Hansen RA, Roth, Brouwer ES, Herndon AS, Christensen DB. Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand. Journal of the American Pharmacists Association. 2006 Nov/Dec;46(6):700-6.

Gartlehner G, Hansen RA, Nissman D, Lohr KN, Carey TS. A simple and valid tool to distinguish efficacy from effectiveness studies. Journal of Clinical Epidemiology. 2006 Oct;59(10):1040-8.

Shaheen NJ, Hansen RA, Gangarosa LM, Ringel Y, Morgan DR, Thiny MT, Russo MW, Sandler RS. The burden of gastrointestinal and liver diseases, 2006. American Journal of Gastroenterology. 2006 Sep;101(9):2128-38.

Fu AZ, Christensen DB, Hansen RA, Liu GG. Second-Generation Antidepressant Discontinuation on Depressive Relapse in Adult Patients with Bipolar Depression: A Retrospective Analysis. Clinical Therapeutics. 2006 Jun;28(6):979-89.

Gartlehner G, Hansen RA, Carson SS, Lohr KN. The efficacy and safety of inhaled corticosteroids in patients with COPD: A systematic review and meta-analysis. Annals of Family Medicine.  2006 May-Jun;4(3):253-62.

Hansen RA, Greene SB, Williams CE, Blalock SJ, Crook KD, Akers R, Carey TS. Medications involved in nursing home errors: targets for quality improvement.  American Journal of Geriatric Pharmacotherapy. 2006 Mar;4(1):52-61.

Trygstad TK, Hansen RA, Wegner SE. Evaluation of product switching behavior in a Medicaid population following a policy change to cover OTC loratadine one year later than market availability.  Journal of Managed Care Pharmacy. 2006; 12(2): 108-20.

Hansen RA, Shaheen NJ, Schommer JC. Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising. Clinical Therapeutics. 2005; 27(9):1478-87.

Blalock SJ, Byrd JE, Hansen RA, Yamanis N, McMullen K, DeVellis BM, et al. Predictors of potentially inappropriate medication drug utilization in a sample of community-dwelling older adults. American Journal of Geriatric Pharmacotherapy. 2005; 3(3): 168-79.

Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS. Efficacy and safety of second-generation antidepressants in major depressive disorder: a meta-analysis. Annals of Internal Medicine. 2005;143(6):415-26.

Schommer JC, Singh R, Hansen RA. Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements. Research in Social and Administrative Pharmacy. 2005;1(2): 231-50.

Hansen RA, Droege M. Methodological challenges surrounding direct-to-consumer advertising research – The measurement conundrum. Research in Social and Administrative Pharmacy. 2005;1(2): 331-47.

Hansen RA, Gartlehner G, Kaufer DJ, Lohr KN, Randolph LC, and Carey T.  Drug class review on Alzheimer’s drugs.  Final AHRQ-approved report available at http://www.ohsu.edu/drugeffectiveness/reports/draft.cfm; accessed June 14, 2005.

Gartlehner G, Hansen RA, Carey TS, Lohr KN, Gaynes BN, Randolph LC. Discontinuation rates for SSRIs and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.  International Journal of Psychopharmacology. 2005; 20: 59-69.

Schommer JC, Hansen RA. The study of direct-to-consumer advertising for prescription drugs.  Research in Social and Administrative Pharmacy. 2005;1(2): 348-68.

Cline RR, Farley JF, Hansen RA, Schommer JC. Osteoporosis beliefs and antiresorptive medication use. Maturitas. 2005 Mar 14;50(3):196-208.

Hansen RA, Schommer JC, Cline RR, Hadsall RS, Schondelmeyer SW, Nyman JA. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.  Research in Social and Administrative Pharmacy. 2005;1(2): 139-57.

Hansen RA, Gartlehner G, Lohr KN, Carson S, and Carey T.  Drug class review on inhaled corticosteroids.  Final AHRQ-approved report available at http://www.ohsu.edu/drugeffectiveness/reports/draft.cfm; accessed January 10, 2005.

Gartlehner G, Hansen RA, Kahwati L, Lohr KN, Gaynes B, and Carey T.  Drug class review on second-generation antidepressants.  Final AHRQ-approved report available at http://www.ohsu.edu/drugeffectiveness/reports/draft.cfm; accessed December 10, 2004.

Farley JF, Cline RR, Hansen RA. Resorptive drug use among community-dwelling women in Minnesota. Am J Health Syst Pharm. 2004 Aug 1;61(15):1577-85.

Schommer JC, Mott DA, Hansen RA, Cline RR. Selected characteristics of senior citizens’ prescription drug payment and procurement in 1998 and 2001. Journal of Managed Care Pharmacy, 2003; 9(5):408-415.

Hansen RA, Schommer JC, Hadsall RS, Larson TA, Schondelmeyer SW, Uden DL. Minnesota pharmacist workforce: a pharmacy perspective. Minnesota Pharmacist. 2001; 55(4): 17-20.

Schommer JC, Hansen RA. A problem well defined is half solved: methodological issues related to the study of  direct-to-consumer advertising (DTCA) for prescription drugs. A paper commissioned by the Department of Health Human Services, Office of the Assistant Secretary for Planning and Evaluation, Washington, DC, Final Post Conference Draft published June 18, 2001, http://aspe.hhs.gov.